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ABSTRACT 
Background and objectives: Dementia with Lewy bodies (DLB) is 
characterized by relative preservation of the medial temporal lobe compared 
to Alzheimer’s disease (AD). However, the differential involvement of the 
hippocampal subfields in both diseases has not been clearly established. We 
aim to investigate hippocampal subfield differences in vivo in a clinical cohort 
of DLB and AD subjects. 
Methods: 104 participants (35 DLBs, 36 ADs, and 35 healthy comparison 
subjects (HC)) underwent clinical assessment and 3 Tesla T1-weighted 
imaging. A Bayesian model implemented in Freesurfer was used to 
automatically segment the hippocampus and its subfields. We also examined 
associations between hippocampal subfields and tests of memory function.  
Results: Both the AD and DLB groups demonstrated significant atrophy of 
the total hippocampus relative to HC but the DLB group was characterized by 
preservation of the CA1, fimbria and fissure. In contrast, all the hippocampal 
subfields except the fissure were significantly atrophied in AD compared to 
both DLB and HC groups. Among DLB subjects, CA1 was correlated with the 
Recent Memory score of the CAMCOG and Delayed Recall subscores of the 
HVLT. 
Conclusions: DLB is characterized by milder hippocampal atrophy that was 
accompanied by preservation of the CA1. The CA1 was also associated with 
memory function in DLB. Our findings highlight the promising role of 
hippocampal subfield volumetry, particularly that of the CA1, as a biomarker 
for the distinction between AD and DLB. 
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1. INTRODUCTION 
Dementia with Lewy bodies (DLB) is the second leading cause of 
degenerative dementia in older people after Alzheimer’s disease (AD), 
accounting for up to 15% of cases at autopsy 1. DLB shares common clinical, 
neuropsychological and pathological features with other dementia subtypes 
such as AD and Parkinson’s disease (PD) with dementia, making 
differentiation between these disorders challenging. Despite the development 
of consensus diagnostic criteria, the sensitivity for differential diagnosis of 
DLB in clinical practice remains low, with many DLB subjects misdiagnosed. 
In light of this uncertainty, and with important implications for subsequent 
patient management, there is need for reliable imaging markers to help 
distinguish DLB from other subtypes of dementia, most especially AD. 
 
Structural neuroimaging studies have found reduced global atrophy in DLB 
compared to AD 2. The relative preservation of the hippocampus in DLB 
compared to AD is recognized as one of the most consistent structural MRI 
findings 2,3, and has been incorporated as a supportive feature in the revised 
criteria for the diagnosis of DLB 1.  
 
However, most previous studies have compared total hippocampal volumes 
using a region of interest approach. Considering the functional specialization 
of the histologically distinct subfields of the hippocampus, local analyses of 
the hippocampus are increasingly recognized as a viable method to 
characterize the involvement of cytoarchitectonic regions in the pathology of 
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neurodegenerative diseases, most commonly in AD, mild cognitive 
impairment (MCI) 4, and PD 5.  
 
Using a manual tracing technique on 4T MRI images, Mueller and colleagues 
6 have demonstrated atrophy of the cornu ammonis (CA)1 and the subiculum 
in AD. Interestingly, a similar pattern of hippocampal changes in healthy 
comparisons (HC) has also been associated with development of amnestic 
MCI 4. There is also histopathological evidence that the CA1 region is 
preferentially vulnerable to the neuropathology of AD 7. 
 
There have been few direct comparisons of the hippocampal subfields in DLB 
and AD. Two previous studies have reported a milder degree of atrophy in the 
subiculum and CA1 regions of the hippocampus in DLB compared to AD 8,9, 
although another study did not find any significant difference in hippocampal 
volumes 10. As such, the clinical utility of hippocampal subfield volumetry to 
aid in the differential diagnosis of DLB from AD remains unclear.  
 
The discrepancy of findings in the literature could be attributed to the 
variability of methods that are currently employed to examine the hippocampal 
subfields. To date, manual tracing is widely acknowledged as the gold 
standard of hippocampal subfield delineation. However, it is labor intensive, 
and its reproducibility might be limited by inter/intra-rater variability. There is 
also the possibility of asymmetric bias in manual segmentations due to 
laterality of visual perception 11. To overcome these limitations, we used a 
validated and automated technique 12 to compare the volumetric differences 
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of the hippocampal subfields in DLB and AD and investigate their associations 
with memory performance.  
 
2. METHODS 
2.1. Subjects, assessment and diagnosis 
Seventy-one individuals over the age of 60 (36 subjects with probable AD 13 
and 35 with probable DLB 1 were recruited from a community dwelling 
population of patients referred to local Old Age Psychiatry, Geriatric Medicine 
or Neurology Services. Thirty-five similarly aged healthy comparison subjects 
were recruited from relatives and friends of subjects with dementia or 
volunteered via advertisements in local community newsletters. The research 
was approved by the local ethics committee. All subjects or, where 
appropriate, their nearest relative, provided written informed consent.  
 
Subjects underwent clinical and neuropsychological evaluation. 
Neuropsychological assessments of global cognitive measures included the 
Cambridge Cognitive Examination (CAMCOG) 14, which incorporates the 
Mini-Mental State Examination (MMSE) 15 in addition to a number of 
subscales assessing domains including orientation, language, memory, 
attention, praxis, calculation, abstract thinking and perception. Verbal and 
visuospatial memory was assessed with the Hopkins Verbal Learning Test 
(HVLT) 16 and the Brief Visuospatial Memory Test (BVMT) respectively 17. 
Motor parkinsonism was evaluated with the Unified Parkinson’s Disease 
Rating Scale Part III (UPDRS) (2003). For subjects with dementia, 
neuropsychiatric features were examined with the Neuropsychiatric Inventory 
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(NPI) 19, and cognitive fluctuations were assessed with the cognitive 
fluctuation scale 20, a test to obtain information about the historical pattern of 
cognitive fluctuation over time in a patient. 
 
2.2. MRI acquisition   
Subjects underwent T1 weighted MR scanning on the same 3T MRI system 
using an 8 channel head coil (Intera Achieva scanner, Philips Medical 
Systems, Eindhoven, Netherlands). The sequence was a standard T1 
weighted volumetric sequence covering the whole brain (3D MPRAGE, 
sagittal acquisition, 1 mm isotropic resolution and matrix size of 240 (anterior-
posterior) x 240 (superior-inferior) x 180 (right-left); repetition time (TR) = 
9.6ms; echo time (TE) = 4.6ms; flip angle = 8o; SENSE factor = 2).  
 
2.3. Image analysis 
Cortical reconstruction and volumetric segmentation of MRI scans were 
processed on the same workstation using the Freesurfer 5.3 image analysis 
suite (http://surfer.nmr.mgh.harvard.edu/). The technical details are described 
previously 21,22. In summary, the initial processing of T1 MRI images includes 
the following steps: removal of non-brain tissue 23, automated Talairach 
transformation, segmentation of the subcortical white matter and deep grey 
matter volumetric structures 24, intensity normalization 25, tessellation of the 
grey matter/white matter boundary, automated topology correction 26, and 
surface deformation to optimally place the grey matter/white matter and grey 
matter/cerebrospinal fluid (CSF) boundaries 21. All surface models in our 
study were visually inspected for accuracy and manual corrections while 
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blinded to diagnostic information. However, 2 subjects (2 AD) with extensive 
pial/white matter surface errors failed the hippocampal segmentations and 
were excluded from the analyses. The dataset for all subsequent analyses 
comprised of 35 HC, 34 AD, and 35 DLB. 
 
Total hippocampal volumes were obtained from the automated pipeline for 
volumetric segmentation of subcortical structures implemented in Freesurfer. 
Subsequently, the hippocampal subfields were segmented by using a 
Bayesian inference approach, and a probabilistic atlas of the hippocampal 
formations based on manual delineations of subfields from several training 
subjects. The left and right hippocampi were segmented into 7 subfields: CA1, 
CA2–3, CA4–DG, subiculum, presubiculum, fimbria, and hippocampal fissure 
(Figure 1). The detailed procedures for subfield delineations have been 
described elsewhere 12.  
 
2.4. Statistical analyses 
Statistical analyses were performed with the STATA13 
(http://www.stata.com/) software. The distribution of continuous variables was 
tested for normality using the Skewness-Kurtosis test and visual inspection of 
histograms. Demographic differences across the three diagnostic groups were 
assessed with ANOVA or Kruskal-Wallice while clinical and cognitive scores 
were compared between DLB and AD using T-Tests or Mann-Whitney 
depending on the normality of distributions.  The χ2 test was used to examine 
gender distributions between groups. Comparisons of hippocampal subfield 
volumes between groups were examined with ANCOVA, controlling for age, 
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gender, education, and intracranial volumes (ICV), followed by post-hoc 
pairwise Bonferroni tests. Subsequently, we also performed Bonferroni 
correction for the number of subfields, with an adjusted significance threshold 
of p = 0.007. Within each group, we further investigated associations of 
hippocampal subfields which were differentially affected with memory 
functions scores using partial correlations to account for the effects of age, 
gender, education, and ICV.  
 
3. RESULTS 
3.1. Subject characteristics 
The demographic and clinical data for patients and healthy comparison 
subjects are summarized in Table 1. Subject groups were well matched for 
age [F(2,101) = 0.74; p = 0.479], gender [x2(2)=4.27; p = 0.118], and years of 
education [x2(2)=5.62; p = 0.060]. As expected, the DLB group had 
significantly higher UPDRS scores than the AD group (Z = -6.817, p < 0.001) 
DLB subjects also scored significantly higher on the Cognitive Fluctuations 
Scale (Z = -3.915, p < 0.001), although there were no significant differences 
between dementia groups in scores of NPI [Z = -0.738, p = 0.461)], MMSE 
[t(67) = -0.5921, p = 0.556], CAMCOG [t(67) = -0.692, p =0.491], and HVLT-
Total Recall [t(66) = -0.086, p = 0.932]. Compared to the DLB group, the AD 
group performed significantly poorer on the HVLT-Delayed Recall [Z = -3.20, 
p = 0.001] and HVLT-Retention [Z = -3.27, p = 0.001]. 
 
3.2. Hippocampal subfields 
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The volumetric comparisons of the hippocampal subfields between groups are 
shown in Figure 2 and Table 2. Overall, ANCOVA analyses revealed a main 
effect of diagnosis on total hippocampal volumes. The AD group showed the 
most atrophy of the hippocampus, with the DLB group being intermediate 
between AD and HC (AD<DLB<HC). The relative extent of hippocampal 
subfield atrophy in DLB and AD compared to the healthy comparison group is 
shown in Table 3. After controlling for age, gender, education, and ICV, we 
found significant atrophy affecting all the hippocampal subfields, with the 
exception of the fissure, in AD compared to both HC and DLB groups. In 
contrast, the CA1, fimbria and the fissure were preserved in DLB relative to 
HC.  
 
3.3 Correlations with memory functions  
Hippocampal subfield analyses revealed that the CA1 volumes in DLB were 
also significantly correlated with the Recent Memory scores of the CAMCOG 
(r = 0.40; p = 0.029) and Delayed Recall scores from the HVLT (r = 0.37; p = 
0.043). The AD group did not show any significant associations of total 
hippocampus and the CA1 with any cognitive test. 
 
4. DISCUSSION  
The main findings of the study were (a) DLB was associated with significantly 
milder hippocampal atrophy than AD; (b) AD showed a global pattern of 
hippocampal atrophy affecting all the subfields with the exception of the 
fissure (c) the CA1 region was relatively preserved in DLB compared to HC 
and AD; (d) the CA1 region is associated with memory functions in DLB.  
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Neuropathological studies have shown that the hippocampus is one of the 
earliest sites of pathology in the disease course of AD, which progresses in a 
systematic fashion: neurofibrillary tangle originates in entorhinal areas before 
spreading to the CA1 and subiculum, and subsequently to the CA2 and CA3 
areas before affecting the neocortex 27. Despite growing evidence suggesting 
that the neurodegenerative pathology is not uniformly distributed throughout 
the hippocampus, the majority of volumetric studies in DLB and AD have  
considered the hippocampus as a unitary structure. Therefore, to appreciate 
the complex anatomical structure of the hippocampus, we used an automated 
technique to compare local volumetric differences in the hippocampus in DLB 
subjects with those of AD and age-matched HC. 
 
In accordance with previous estimates of hippocampal atrophy ranging from 
23% 8,9 – 28% 28, we demonstrated that AD subjects had 29.5% smaller 
hippocampal volumes relative to HC. At the subregional level, we found that 
AD group had significant atrophy in all hippocampal subfields compared to 
both DLB and HC, with the exception of the fissure. Our finding is 
corroborated by previous imaging studies 29, including post-mortem evidence 
indicating greater CA1, CA2, CA3, and subiculum atrophy in AD relative to HC 
30,31. Taken together, the global pattern of hippocampal atrophy observed in 
our AD group is congruent with a previous finding that subfield measurements 
may not confer additional sensitivity over total hippocampus volumes in the 
detection of AD 32. 
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The relative preservation of the hippocampus in DLB compared to AD is in 
agreement with the literature 2 and fits with the different neuropsychological 
profiles of each group, where memory deficits are more prominent in AD. 
Previous studies have also suggested that DLB is associated with lesser 
pathology affecting the perforant pathways 33.  
 
To date, only a few studies have compared atrophy patterns of the 
hippocampal subfields between DLB and AD with considerable heterogeneity 
in methodologies and findings. The CA1, fimbria, and fissure were the most 
preserved regions in our DLB subjects. Interestingly, the present results are in 
partial agreement with previous work from our group 8. In that study, we used 
a manual drawing approach and reported a lower degree of atrophy affecting 
the CA1 and subiculum regions in DLB compared to AD. It is noteworthy that 
our findings, despite different methodologies (automatic segmentation v 
manual tracing), are also consistent with histopathological evidence in DLB, 
indicating that neuronal loss and Lewy neurites are largely confined to the 
presubiculum and the CA2-3, with sparing of the CA1 and subiculum regions 
31. However, two previous studies, employing the hippocampal radial distance 
technique, have reported increased atrophy, rather than preservation, of the 
CA1 in DLB relative to HC 9,10. Methodological differences in the anatomical 
delineations of the subfields might account for the conflicting findings. The 
CA1 as well as other hippocampal structures are parallel to each other and 
are organized along the anterior-medial to posterior-lateral axis of the 
hippocampus. The hippocampal radiance distance technique, which 
measures in perpendicular directions to this axis, might be limited in its 
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capacity to reveal differential volume changes in CA1 and other subfields, and 
in fact, over-estimate the volume reduction of CA1 due to atrophy of other 
parallel structures.  
  
The hippocampus is a complex structure, with interconnected subfields having 
different projections. The CA1 has extensive reciprocal projections with the 
enthorinal cortex 34 and emerging evidence from high-resolution 4T imaging 35 
and lesion 36 studies have pointed toward a critical involvement of CA1 
neurons in episodic memory functions. The preservation of the CA1 region in 
DLB subjects also parallels with significantly better memory function 
compared to AD in our study. Furthermore, consistent with our previous work 
8, the CA1 volumes in our DLB group were also significantly associated with 
memory functions. We are not aware of other studies that have examined 
correlations of hippocampal subfields with cognitive measures in DLB.  
 
Although a previous study using the same Freesurfer technique has reported 
a correlation between hippocampal volumes and delayed recall scores in AD 
37, we did not find any significant association in the AD group with memory 
function, most likely due to a floor effect of memory performance. In future, 
the domain-specific contribution of hippocampal subfields will be better 
understood as this automated technique receives more recognition.  
 
 The major strengths of the study include the comprehensive 
neuropsychological assessment and a well-characterized group of probable 
DLB and AD subjects. Furthermore, in light of significant disparities in age 10, 
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gender and education 9 across comparison groups in previous studies, we 
extend the literature by investigating a cohort that was matched for age, 
gender, and educational level. We also used a publicly available technique 
that is capable of segmenting the hippocampal subfields in a reproducible and 
automatic fashion. Thus, we are able to address limitations associated with 
manual delineations of the hippocampus (see Introduction) and the practical 
challenges of processing large datasets. Lastly, this technique has also been 
validated against manual volume estimations 12.  Nevertheless, the 
operational definition of the medial boundaries of CA1 varies between 
segmentation protocols, resulting in a smaller volume of CA1 for the 
Freesurfer technique compared to other studies 8,38. Also, whilst this method 
reports a combined volume of CA2 + CA3, others have reported CA2 
separately, and combined CA3 with CA4 and DG. In addition, Van Leemput et 
al originally assessed hippocampal subfields with ultra-high resolution 
MPRAGE (slice thickness = 0.8mm) and enhanced signal-to-noise ratio 12. 
Consistent with other studies, we used a standard 3T MPRAGE acquisition 
sequence (slice thickness = 1mm isotropic). However, this automated 
technique has been used to segment hippocampal subfields from 1.5T scans 
with a much lower resolution and a longer acquisition time of 35 minutes 5. 
Finally, although this technique has been widely applied in neurodegenerative 
diseases, the probabilistic atlas from Van Leemput et al was built upon 
healthy subjects, although this is an inherent limitation in many imaging 
studies where a common template is necessary for the investigation of group 
differences. Hence, some caution must be exercised in comparing findings 
between studies.  
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Additional potential limitations of this study include the lack of 
neuropathological verification of AD and DLB, as subject groups were based 
on clinical diagnosis, though this is an inherent limitation of all ante-mortem 
imaging studies. Furthermore, we have previously demonstrated good 
agreement between clinical and pathological diagnosis using the consensus 
clinical diagnostic method adopted here 39. 
 
5. CONCLUSION 
To date, very few studies have compared atrophy patterns of the hippocampal 
subfields in DLB and AD. The main findings of (a) CA1 preservation and (b) 
milder global hippocampal atrophy in a clinically diagnosed DLB subjects are 
largely consistent with the topography of neuronal loss described in 
histopathological studies as well as with previous imaging studies. The distinct 
involvement of the CA1 in DLB and AD suggests that hippocampal subfield 
volumetry could be a promising biomarker to aid in the differential diagnosis of 
DLB.  
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TABLES AND FIGURES 
 
 
Table 1. Demographics, clinical and neuropsychological measures. 
Values expressed as Mean  1SD. § χ2– Chi-Square (df = 2) ; a ANOVA; k 
Kruskal-Wallis test (df = 2). w Mann-Whitney test – AD and DLB; † Student’s t-
test (df = 67) – AD and DLB.  Abbreviations: DLB = dementia with Lewy 
bodies; AD = Alzheimer’s disease; HC = Healthy comparison subjects; 
UPDRS = Unified Parkinson’s Disease Rating Scale, Part III; NPI = 
Neuropsychiatry Inventory; CogFluct = Cognitive Fluctuation Scale; MMSE = 
Mini-Mental State examination; CAMCOG = Cambridge Cognitive 
Examination; HVLT = Hopkins Verbal Learning Test; BVMT = Brief 
Visuospatial Memory Test. 
 
 
 
 
 
 
 
HC 
 
DLB 
 
AD 
 
p value 
     
n 35 35 34  
Gender (m:f) 20:15 27:8 19:15 χ2=4.27, 0.118§ 
Age (yrs) 76.7 ± 5.2 78.4 ± 6.9 78.1 ± 5.8 F2,101=0.74, p=0.479a 
Education (yrs) 11.7 ± 2.6 10.8 ± 2.6 11.1 ± 3.5 p=0.060 k * 
UPDRS  2.0 ± 1.9 26.0 ± 10.7 5.6 ± 4.4 p<0.001 w * 
NPI   21.5 ± 17.1 17.0 ± 12.2 p=0.461 w 
CogFluct  6.1 ± 3.8 2.3 ± 3.7 p<0.001 w * 
MMSE 29.1 ± 1.0 20.3 ± 5.3 19.6 ± 4.5 p=0.556 † 
CAMCOG 97.3 ± 3.8 67.7 ± 15.2 65.4 ± 12.2 p=0.491 † 
HVLT-Total Recall 25.9 ± 4.6 10.8 ± 4.8  10.7 ± 5.0 p=0.932 † 
HVLT-Delay Recall 8.5 ± 2.9 1.7 ± 2.3 0.3 ± 0.8 p=0.001 w * 
HVLT-Retention 80.6 ± 22.7 30.2 ± 38.0 4.1 ± 12.2 p=0.001 w * 
BVMT-Total 18.8 ± 6.5 6.9 ± 6.7  4.0 ± 2.5 p=0.119 w 
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Hippocampal 
subfields (mm3) 
HC  (N=35) DLB (N=35) AD (N=34) Group 
comparisons 
(df=2) mean sd mean sd mean sd 
Total 5456 702 4894 775 3848 716 p<0.001a,b,c,d * 
Presubiculum 823 92 688 136 562 101 p<0.001a,b,c,d * 
CA1 
650 58 608 94 528 116 
p<0.001 a, b * 
p=0.002c * 
p=0.082 d 
CA2-3 1828 200 1574 293 1312 257 p<0.001a,b,c,d * 
Fimbria 
113 30 100 42 74 35 
p<0.001a,b * 
p=0.005c * 
p=0.615d 
Subiculum 1163 109 999 166 815 140 p<0.001a,b,c,d * 
CA4-DG 1040 106 895 158 743 144 p<0.001a,b,c,d * 
Fissure 128 37 125 42 132 46 p=0.867a 
 
Table 2. Volumetric comparisons of hippocampal subfields in AD (n=34), 
DLB (n=35), and HC (n=35), in mean (SD). a ANCOVA [df=2] controlling for 
age, gender, education, and intracranial volumes with post-hoc Bonferroni 
pairwise tests: b AD < HC; c AD < DLB; d DLB < HC. After Bonferroni 
correction for the number of subfields, the significance threshold is set at p = 
0.007. Abbreviations: HC = Healthy comparison subjects ; AD = Alzheimer’s 
disease; DLB = Dementia with Lewy bodies; CA = cornu Ammonis; DG = 
Dentate gyrus.  
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Relative extent of atrophy 
compared to HC  
 
  
AD DLB 
Total Hippocampus 
 
-29.5% -10.3% 
Presubiculum 
 
-31.7% -16.3% 
CA1 
 
-18.6% -6.3% 
CA2-3 
 
-28.3% -13.9% 
Fimbria 
 
-34.5% -11.6% 
Subiculum 
 
-29.9% -14.1% 
CA4-DG 
 
-28.5% -13.9% 
Fissure 
 
2.6% -2.6% 
 
Table 3. Relative extent of total and regional hippocampal atrophy in AD 
and DLB compared to healthy comparison subjects.  
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Figure 1. Segmented hippocampal subfields from each representative 
subject in all three diagnostic groups. 
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Figure 2. Volumetric comparisons of hippocampal subfields in AD 
(n=34), DLB (n=35), and HC (n=35), in mean (SD). The bars in the figure 
represent standard error bars. Abbreviations: HC = Healthy comparison 
subjects; AD = Alzheimer’s disease; DLB = Dementia with Lewy bodies; CA = 
cornu ammonis; DG = Dentate gyrus. 
